AI assistant
Sending…
Organon & Co. — Director's Dealing 2022
Jun 14, 2022
31461_dirs_2022-06-14_851fbd71-6b14-48c0-96ca-3739281080cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2022-06-10
Reporting Person: Gayle Helene D (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-10 | Phantom Stock | $ | A | 5640 | Acquired | Common Stock (5640) | Direct |
Footnotes
F1: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3: Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022.
More from Organon & Co.
Environmental & Social Information
2026
May 29
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
M&A Activity
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3